Skip to content

Addiction: all studies

Page 441 of 855: studies 4,401 to 4,410 of 8,547, newest first. Back to the addiction overview

Research

Mindfulness-induced endogenous theta stimulation occasions self-transcendence and inhibits addictive behavior.

Science Advances October 14, 2022 Eric L Garland, Adam W. Hanley, Justin Hudak et al. 39 citations

Self-regulation is instantiated by theta oscillations (4 to 8 Hz) in neurons of frontal midline brain regions. Frontal midline theta (FMΘ) is inversely associated with default mode network (DMN) activation, which subserves self-referential processing. Addiction involves impaired self-regulation and DMN dysfunction. Mindfulness is an efficacious self-regulatory practice for treating addiction,...

An open-label study evaluating the safety, behavioral, and electrophysiological outcomes of low-dose ketamine in children with ADNP syndrome.

HGG advances October 13, 2022 Alexander Kolevzon, Tess Levy, Sarah Barkley et al.

Activity-dependent neuroprotective protein (ADNP) syndrome is a rare genetic condition associated with intellectual disability and autism spectrum disorder. Preclinical evidence suggests that low-dose ketamine may induce expression of ADNP and that neuroprotective effects of ketamine may be mediated by ADNP. The goal of the proposed research was to evaluate the safety, tolerability, and...

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis

Psychopharmacology October 13, 2022 Nadia R. P. W. Hutten, Thomas R. Arkell, Frederick Vinckenbosch et al. 36 citations

RATIONALE: Delta-9-tetrahydrocannabinol (THC), an active component of cannabis, can cause anxiety in some users during intoxication. Cannabidiol (CBD), another constituent of cannabis, has anxiolytic properties suggesting that cannabis products containing CBD in addition to THC may produce less anxiety than THC-only products. Findings to date around this issue have been inconclusive and could...

Structure–Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor

Biomolecules & Therapeutics October 13, 2022 Shujie Wang, Anlin Zhu, Suresh Paudel et al. 3 citations

Among 14 subtypes of serotonin receptors (5-HTRs), 5-HT2AR plays important roles in drug addiction and various psychiatric disorders. Agonists for 5-HT2AR have been classified into three structural groups: phenethylamines, tryptamines, and ergolines. In this study, the structure-activity relationship (SAR) of phenethylamine and tryptamine derivatives for binding 5-HT2AR was determined. In...

DOI: 10.4062/biomolther.2022.096 (opens in new tab) Phenethylamines Tryptamines Stereochemistry Pharmacology

Use of psychoactive and stimulant plants on the south coast of Peru from the Early Intermediate to Late Intermediate Period

Journal of Archaeological Science October 13, 2022 Dagmara M. Socha, Marzena Sykutera, Giuseppe Orefici 15 citations

The preservation of naturally mummified bodies in the Nazca drainage and Yauca Valley provided an opportunity to analyse for the first time which of the psychoactive plants were used on the southern Peruvian coast. Toxicological analysis allows us to better understand the ancient medicine, trade network and religiosity of the region of interest. Hair samples of 22 individuals (including four...

The dynamic uncertainty of narrative, place, and practice in spiritual experience: Clues from the phenomenology of walking a labyrinth

Archive for the Psychology of Religion October 10, 2022 Jonathan Doner

Labyrinths have held the fascination of people since ancient times. Although walking a labyrinth can simply be an interesting recreation, it has increasingly been seen as an intentional tool for personal or spiritual growth. Religious and spiritual experience is generally understood to be a product of the kinds of evidence given within the experience as well as the person’s cognitive and...

O Renascimento da Medicina Psicodélica

E-Acadêmica October 10, 2022 Roberto Carlos Moreira Kuligowski, Eduarda Maria Schroeder, João Vitor Pelizzari et al.

Introduction: Studies about alternative medicine have multiplied in several countries such as the United States, Norway and England in recent years. Among them, I highlight psychedelic medicine that through randomized clinical trials, has already shown that psilocybin - substance present in the Psilocybe cubensis mushroom, popularly known as "magic mushrooms" - was able to induce remission of...

An EEG Classifier to Discriminate Between Focused Attention Meditation and Problem-solving

IEEE International Conference on Systems, Man and Cybernetics October 9, 2022 Gansheng Tan, Shui-Bo Wang, Valentin Vierge et al.

Digital platforms could facilitate meditation practice by discriminating the participants’ mental state in real time based on neural activities. However, the search for neural correlates of meditative states yields contradictory results in the literature. To identify the neural signature of meditation, we propose a Random Forest classifier to discriminate between a Focused Attention Meditation...

The treatment of depression — searching for new ideas

Frontiers in Pharmacology October 7, 2022 Katarzyna Stachowicz, Magdalena Sowa-Kućma 48 citations

Depression is a severe mental health problem that affects people regardless of social status or education, is associated with changes in mood and behavior, and can result in a suicide attempt. Therapy of depressive disorders is based mainly on drugs discovered in the 1960s and early 1970s. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs)...

DOI: 10.3389/fphar.2022.988648 (opens in new tab) Serotonin Monoaminergic Antidepressant Pharmacology +1

Chronic cannabis use affects cerebellum dependent visuomotor adaptation.

Journal of Psychiatric Research October 6, 2022 C. Blithikioti, L. Miquel, B. Paniello et al.

BACKGROUND Cannabis is one of the most commonly used substances in the world. However, its effects on human cognition are not yet fully understood. Although the cerebellum has the highest density of cannabinoid receptor type 1 (CB1R) in the human brain, literature on how cannabis use affects cerebellar-dependent learning is sparse. This study examined the effect of chronic cannabis use on...